Capital Market Reactions to The Covid 19 Pandemic
DOI:
https://doi.org/10.58344/jws.v2i3.252Keywords:
biotechnology, capital, covid-19, stocks, vaccinesAbstract
This study aims to determine and analyze the capital market's reaction to the Covid 19 Pandemic in biotechnology companies listed on the Nasdaq. The method used in this study uses a type of quantitative method. This study uses an event study. The sampling method in this study was carried out using a non-probability random sampling approach. The announcement of the COVID-19 pandemic by the WHO and the commitment to produce a COVID-19 vaccine have had a significant impact on abnormal stock returns and trading volume activities of biotech companies listed on the NASDAQ stock market. However, there is no significant effect on the liquidity of biotech company stocks. In addition, the announcement of the COVID-19 pandemic also affected the volatility of biotech company stocks. In contrast, the announcement of a commitment to producing a COVID-19 vaccine did not significantly impact the volatility of biotech company stocks. So, it shows that the NASDAQ stock market reacts sensitively to announcements about the COVID-19 pandemic and efforts to produce COVID-19 vaccines by biotech companies. This shows that the COVID-19 pandemic has significantly impacted the stock market, especially in the biotechnology sector. The event study approach is used to test the market with a semi-strong form of market efficiency by demonstrating that the stock price reflects all published information (all publicly available information).
References
Al-Awadhi, A. M., Alsaifi, K., Al-Awadhi, A., & Alhammadi, S. (2020). Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns. Journal of Behavioral and Experimental Finance, 27, 100326. https://doi.org/10.1016/j.jbef.2020.100326
Alam, M. N., Alam, M. S., & Chavali, K. (2020). Stock market response during COVID-19 lockdown period in India: An event study. The Journal of Asian Finance, Economics and Business, 7(7), 131–137.
Chebbi, K., Ammer, M. A., & Hameed, A. (2021). The COVID-19 pandemic and stock liquidity: Evidence from S&P 500. The Quarterly Review of Economics and Finance, 81, 134–142. https://doi.org/10.1016/j.qref.2021.05.008
Cucinotta, D., & Vanelli, M. (2020). WHO declares COVID-19 a pandemic. Acta Bio Medica: Atenei Parmensis, 91(1), 157. doi: 10.23750/abm.v91i1.9397
Göker, ?. E. K., Eren, B. S., & Karaca, S. S. (2020). The impact of the COVID-19 (coronavirus) on the borsa ?stanbul sector index returns: an event study. Gaziantep University Journal of Social Sciences, 19(COVID-19 Special Issue), 14–41. https://doi.org/10.21547/jss.731980
Hwang, T. J. (2013). Stock market returns and clinical trial results of investigational compounds: an event study analysis of large biopharmaceutical companies. PloS One, 8(8), e71966. https://doi.org/10.1371/journal.pone.0071966
Indrayono, Y. (2021). What Factors Affect Stocks’ Abnormal Return during the COVID-19 Pandemic: Data from the Indonesia Stock Exchange: Data from the Indonesia Stock Exchange. European Journal of Business and Management Research, 6(6), 1–11.
Ingale, K. K., & Paluri, R. A. (2022). Financial literacy and financial behaviour: A bibliometric analysis. Review of Behavioral Finance, 14(1), 130–154.
Khan, K., Zhao, H., Zhang, H., Yang, H., Shah, M. H., & Jahanger, A. (2020). The impact of COVID-19 pandemic on stock markets: An empirical analysis of world major stock indices. The Journal of Asian Finance, Economics and Business, 7(7), 463–474.
Liu, H., Wang, Y., He, D., & Wang, C. (2020). Short term response of Chinese stock markets to the outbreak of COVID-19. Applied Economics, 52(53), 5859–5872.
Onali, E. (2020). Covid-19 and stock market volatility. Available at SSRN 3571453.
Ozdurak, C., Alcan, G., & Guvenbas, S. D. (2020). The impact of Covid-19 to global pharmaceuticals and biotechnology company stocks returns. Journal of Business Economics and Finance, 9(2), 68–79. https://doi.org/10.17261/Pressacademia.2020.1215
Piñeiro-Chousa, J., López-Cabarcos, M. Á., Quiñoá-Piñeiro, L., & Pérez-Pico, A. M. (2022). US biopharmaceutical companies’ stock market reaction to the COVID-19 pandemic. Understanding the concept of the ‘paradoxical spiral’from a sustainability perspective. Technological Forecasting and Social Change, 175, 121365. https://doi.org/10.1016/j.techfore.2021.121365
Sayed, O. A., & Eledum, H. (2021). The short?run response of Saudi Arabia stock market to the outbreak of COVID?19 pandemic: An event?study methodology. International Journal of Finance & Economics. https://doi.org/10.1002/ijfe.2539
Sohrabi, C., Alsafi, Z., O’Neill, N., Khan, M., Kerwan, A., Al-Jabir, A., Iosifidis, C., & Agha, R. (2020). World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery, 76, 71–76. https://doi.org/https://doi.org/10.1016/j.ijsu.2020.02.034
Vaverková, M. D., Paleologos, E. K., Dominijanni, A., Koda, E., Tang, C.-S., Ma?gorzata, W., Li, Q., Guarena, N., Mohamed, A.-M. O., & Vieira, C. S. (2020). Municipal solid waste management under COVID-19: challenges and recommendations. Environmental Geotechnics, 8(3), 217–232. https://doi.org/10.1680/jenge.20.00082
Wang, Y.-H., Yang, F.-J., & Chen, L.-J. (2013). An investor’s perspective on infectious diseases and their influence on market behavior. Journal of Business Economics and Management, 14(sup1), S112–S127. https://doi.org/10.3846/16111699.2012.711360
Zaremba, A., Aharon, D. Y., Demir, E., Kizys, R., & Zawadka, D. (2021). COVID-19, government policy responses, and stock market liquidity around the world: A note. Research in International Business and Finance, 56, 101359. https://doi.org/10.1016/j.ribaf.2020.101359
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Woro Umayi Ananda
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
